PubMed Health⌕ Search

PubMed · 10218426

[Cooperation between clinicians and pathologists].

Abstract

The present review demonstrates, how co-operation between clinicians and pathologists may be improved. In the present work the problems of artefacts introduced in biopsy specimens are discussed. The circumstances that can result in artefacts include: errors by the surgeon or assistant in handling the tissue at the time of biopsy, an improper fixation and faulty tissue processing. Different types of artefacts are described and illustrated and clinical and technical suggestions are given to prevent alterations of normal morphologic and cytologic features that can compromise an accurate diagnosis. In order to avoid diagnostic errors also anamnestic details and rare lesions must be known. The fate of patients suffering from carcinoma is influenced by the stage of the tumour at the time of diagnosis. It may be impossible to diagnose the tumor with the first biopsy even though clinical and macroscopic aspects suggest malignancy. In such a case a new representative biopsy is necessary as rapidly as possible to preserve the organ.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Reiss, G Reiss. 1999-03-11. [Cooperation between clinicians and pathologists].. https://pubmed.ncbi.nlm.nih.gov/10218426/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗